Answers are grounded in this paper and cite their sources.
Comparative study reveals delayed salivary paracetamol elimination in diabetic patients, indicating altered drug clearance linked to fasting blood sugar.
Salivary elimination of paracetamol was studied in nine type I and ten type II diabetics. Ten healthy volunteers served as a control group. 2. A significant increase in the elimination half-life (t1/2) and apparent volume of distribution was observed in type I diabetics compared with controls. Clearance rate (CL) was not significantly altered. 3. In type II diabetics paracetamol elimination t1/2 was significantly increased with a corresponding decrease in CL. Apparent volume of distribution of the drug was not significantly different. 4. Paracetamol elimination t1/2 had significant correlation with fasting blood sugar values.
No takes yet. Share an insight, caveat, or question.
Adithan et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: